This is a StreetInsider.com Premium Only Page

(XERS) – StreetInsider.com Reports

Mar 27, 2024 04:04 PM Oppenheimer Starts Xeris Pharmaceuticals (XERS) at Outperform, 'successful commercial execution will continue to drive top-line growth'

Mar 7, 2024 06:39 AM Xeris Pharmaceuticals (XERS) PT Raised to $6 at H.C. Wainwright

Mar 6, 2024 07:04 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q4 EPS by 1c, provides guidance

Jan 10, 2024 09:02 AM Xeris Pharmaceuticals Inc. (XERS) Enters Into an Exclusive Worldwide License Agreement for Xeriject Formulation of Teprotumumab

Jan 4, 2024 07:04 AM Xeris Pharmaceuticals (XERS) Updates 2023 Outlook

Nov 13, 2023 06:41 AM Xeris Pharmaceuticals (XERS) PT Lowered to $5.50 at H.C. Wainwright

Nov 10, 2023 07:36 AM Xeris Pharmaceuticals (XERS) PT Lowered to $4 at Piper Sandler

Nov 9, 2023 07:05 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 1c

Oct 16, 2023 07:01 AM Xeris Pharmaceuticals Inc. (XERS) Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4

Sep 27, 2023 08:07 AM Xeris Pharmaceuticals Inc. (XERS) Announces Private Convertible Note Exchange Transactions

Aug 28, 2023 07:35 AM Craig-Hallum Starts Xeris Pharmaceuticals (XERS) at Buy

Aug 8, 2023 07:08 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q2 EPS by 2c, beats revenue

Jul 31, 2023 07:04 AM Xeris (XERS) Ships One Millionth Gvoke Unit

May 9, 2023 08:04 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q1 EPS by 3c; Offer Guidance

Apr 18, 2023 07:00 AM Xeris Pharmaceuticals (XERS) Issued US Patent Covering XeriSol Formulations

Mar 30, 2023 07:04 AM Xeris Pharmaceuticals (XERS) Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect

Mar 29, 2023 04:06 PM Xeris Pharmaceuticals (XERS) Appoints Ricki Fairley to its Board

Mar 8, 2023 06:30 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 5c; Offers Guidance

Jan 30, 2023 07:03 AM Xeris Pharmaceuticals Inc. (XERS) Granted FDA Orphan-drug Exclusivity for Recorlev

Jan 5, 2023 07:04 AM Xeris Pharmaceuticals (XERS) Revises 2022 Outlook Upwards

Dec 15, 2022 07:05 AM Xeris Pharmaceuticals (XERS) Announces Plans for Phase II Dose-Finding Study for Its Investigational Subcutaneous Levothyroxine as Replacement Therapy for Hypothyroidism

Nov 23, 2022 06:03 AM Xeris (XERS) Enters Research Collaboration and Option Agreement With Horizon (HZNP) for XeriJect Formulation of Teprotumumab

Nov 9, 2022 07:17 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 3c

Oct 20, 2022 04:26 PM Jefferies Assumes Xeris Pharmaceuticals (XERS) at Buy

Oct 20, 2022 06:40 AM Xeris Pharmaceuticals (XERS) Reports Positive Phase 1 Clinical Data of Levothyroxine

Aug 10, 2022 07:06 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q2 EPS by 3c

Aug 1, 2022 07:30 AM Xeris Pharmaceuticals' (XERS) Partner Tetris Pharma Acquires by Arecor Therapeutics

Apr 28, 2022 07:13 AM Craig-Hallum Starts Xeris Pharmaceuticals (XERS) at Buy

Mar 16, 2022 06:14 AM Mizuho Securities Reiterates Xeris Pharmaceuticals (XERS), Lowers PT to $6

Mar 10, 2022 07:02 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q4 EPS by 18c

Jan 31, 2022 07:03 AM Xeris Pharmaceuticals Inc. (XERS) Announces Recorlev Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome

Jan 28, 2022 04:42 PM Xeris Pharmaceuticals Inc. (XERS) Files $250M Mixed Shelf

Jan 28, 2022 04:36 PM Xeris Pharmaceuticals Inc. (XERS) Announces 15.36M Share Offering by Selling Stockholders

Jan 18, 2022 07:04 AM Xeris Pharmaceuticals Inc. (XERS) Reaffirms 2021 Guidance and Provides Business Update

Jan 3, 2022 07:03 AM Xeris Pharmaceuticals Inc. (XERS) Enters Into Agreement for $30 Million Private Placement

Dec 31, 2021 10:36 AM Increasing unusual option volume: XERS BDSI ASHR ALLK RSI

Dec 31, 2021 06:38 AM Xeris Pharmaceuticals (XERS) PT Raised to $8 at SVB Leerink

Dec 31, 2021 06:34 AM Xeris Pharmaceuticals (XERS) PT Raised to $5.40 at H.C. Wainwright

Dec 30, 2021 05:43 PM Xeris Biopharma (XERS) Stock Jumps 28% on FDA Approval of Recorlev

Dec 30, 2021 04:39 PM Xeris Pharmaceuticals Inc. (XERS) to resume trading at 5PM ET following FDA approval

Dec 30, 2021 04:31 PM Xeris Pharmaceuticals Inc. (XERS) Granted FDA Approval for Recorlev to Treat Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome

Dec 30, 2021 04:00 PM Xeris Pharmaceuticals Inc. (XERS) halted, news pending

Dec 1, 2021 04:58 PM Mizuho Securities Assumes Xeris Pharmaceuticals (XERS) at Buy

Nov 17, 2021 06:42 AM SVB Leerink Starts Xeris Pharmaceuticals (XERS) at Outperform

Nov 10, 2021 07:22 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c

Oct 29, 2021 06:30 AM UPDATE: H.C. Wainwright Starts Xeris Pharmaceuticals (XERS) at Buy

Oct 25, 2021 07:33 AM Xeris Pharmaceuticals Inc. (XERS) Enters Collaboration Agreement With Merck (MRK)

Sep 8, 2021 04:04 PM Strongbridge Biopharma (SBBP) Shareholders Approve Acquisition by Xeris Pharmaceuticals (XERS)

Sep 1, 2021 07:31 AM Xeris Pharmaceuticals Inc. (XERS) Phase 1 Levothyroxine Study Enrollment Completed

Aug 30, 2021 07:31 AM ISS Recommends Strongbridge Biopharma (SBBP) Shareholders Vote for Xeris Pharmaceuticals (XERS) Deal